The emerging therapy of this peptide represents a exciting breakthrough in the care of diabetes mellitus type 2. Different to existing therapies, tirzepatide affects dual pathways – GLP-1 and the GIP hormone – https://tirzepatide-peptide907691.post-blogs.com/62972826/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment